Skip to content

Prevalence of wheat sensitivity among patients with persistent abdominal symptoms

To study the prevalence of non-celiac wheat sensitivity among patients with functional dyspepsia and IBS symptoms

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037323
Enrollment
168
Registered
2021-10-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K00-K95- Diseases of the digestive system

Interventions

Intervention1: Gluten free diet: A gluten-free diet is a diet that excludes foods containing gluten. Gluten is a protein which is found in wheat, barley, rye and triticale (a cross between wheat and r

Sponsors

Dayanand Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Persistent GI symptoms (dyspepsia, bloating, pain abdomen, diarrhoea, constipation etc.) 2. Negative serum anti-transglutaminase (anti-TTg) 3. Negative wheat specific IgE Antibody 4. Normal duodenal biopsy (except increase of intraepithelial lymphocytes (Marsh I) or eosinophilia)

Exclusion criteria

Exclusion criteria: 1. Presence of other disease that can explain persistent GI symptoms (celiac disease, wheat allergy, irritable bowel syndrome, lactose intolerance, diabetes mellitus, hypercalcemia, thyroid disease, biliary/pancreatic causes, H. pylori infection etc.) 2. Patients on self GFD 3. Use of certain medications leading to dyspeptic symptoms 4. Previous history of any GI surgery/GI disorder 5. Major psychiatric disorder 6. Patients who refuse to comply with the study protocol

Design outcomes

Primary

MeasureTime frame
To study the prevalence of non-celiac wheat sensitivity among patients with functional dyspepsia and IBS like symptomsTimepoint: 9 weeks

Secondary

MeasureTime frame
To study the improvement in symptoms in patients with NCWS on GFD To study the improvement in quality of life in patients with NCWS on GFD Timepoint: 9 weeks

Countries

India

Contacts

Public ContactOmesh Goyal

Dayanand Medical College and Hospital

goyalomesh@yahoo.co.in9914821155

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026